Co-occurrence of oculocutaneous albinism type 2 and mild sickle cell disease explained by HbS/βthal genotype in an individual from the Democratic Republic of Congo.


Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 02 05 2022
revised: 26 07 2022
accepted: 07 08 2022
pubmed: 15 8 2022
medline: 16 9 2022
entrez: 14 8 2022
Statut: ppublish

Résumé

Oculocutaneous albinism type 2 (OCA2) is a pigmentation disorder characterized by hypopigmentation of the skin, hair and eyes and ocular features. Sickle cell disease (SCD) is caused either by homozygosity of the beta globin gene variant c.20A > T/p.Glu6Val giving rise to severe anemia or by combined abnormal hemoglobins (HbS/βthal) leading to mild SCD. We report a 45 years old female patient from the Democratic Republic of Congo affected with these two disorders. She presented with creamy white skin and numerous pigmented patches called dendritic freckles, nystagmus, foveal hypoplasia grade 2, photophobia and very poor visual acuity. Sequencing of the OCA2 gene identified the common exon 7 deletion and a new pathogenic variant c.1444A > C/p.Thr482Pro. She had mild SCD with a total Hb level of 101 g/l. Hbβ sequencing identified variants c.20A > T giving rise to HbS and c.315 + 1 G > A characteristic of β-thalassemia. A heterozygous 3.7 kb deletion of the α globin gene was also found. The combined Hbβ/α globin genotype explains the mild SCD phenotype. Co-occurrence of OCA2 and SCD raises the question whether the patient's phenotype simply results from the addition of the two diseases' phenotypes or whether interaction between the two diseases modulates the phenotype of each other.

Identifiants

pubmed: 35964929
pii: S1769-7212(22)00175-6
doi: 10.1016/j.ejmg.2022.104594
pii:
doi:

Substances chimiques

Carrier Proteins 0
alpha-Globins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104594

Informations de copyright

Copyright © 2022 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare they have no conflict of interest.

Auteurs

Robert Aquaron (R)

Faculté de Médecine, Aix-Marseille Université, 27 Boulevard Jean Moulin, 13385, Marseille, cedex 5, France.

Eulalie Lasseaux (E)

Service de Génétique Médicale, CHU de Bordeaux, Hôpital Pellegrin, 1 place Amelie Raba Léon, 33076, Bordeaux Cedex, France.

Joseph Kelekele (J)

Cliniques Universitaires de Kinshasa, Département d'Ophtalmologie. UNIKIN. Mont Amba, Kinshasa, Democratic Republic of the Congo, The.

Nathalie Bonello-Palot (N)

Laboratoire de Génétique Moléculaire, Hôpital d'enfants de la Timone, Marseille, France.

Catherine Badens (C)

Laboratoire de Génétique Moléculaire, Hôpital d'enfants de la Timone, Marseille, France.

Benoit Arveiler (B)

Service de Génétique Médicale, CHU de Bordeaux, Hôpital Pellegrin, 1 place Amelie Raba Léon, 33076, Bordeaux Cedex, France; Laboratoire Maladies Rares, Génétique et Métabolisme, INSERM U 1211, Université de Bordeaux, France. Electronic address: benoit.arveiler@chu-bordeaux.fr.

Leon Tshilolo (L)

Centre Hospitalier Monkole, CEFA/ Institut de Recherche Biomédicale, Mont-Ngafula, BP 817, Kinshasa, Democratic Republic of the Congo, The.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH